Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Operations

Set Alert for Operations

Biomin launches new premix production facility in Austria

Austrian animal nutrition specialist Biomin has unveiled its new state-of-the-art premix production facility in Haag am Hausruck.

Austria Operations

K-State secures government funding to establish zoonotic infectious disease facility

Kansas State University has snared a $11.3 million grant to develop a new Center of Emerging and Zoonotic Infectious Diseases (CEZID).

Research Operations

Bimeda Biologicals established in Texas

Ireland's Bimeda has renamed its recently acquired vaccine business in the US.

Operations

Zomedica gets full $20m in fundraising effort

Zomedica Pharmaceuticals has added $20 million in funding after securing the full amount of a public offering of shares.

Operations Investments

GALVmed establishes trio of initiatives in West Africa

The Global Alliance for Livestock Veterinary Medicines (GALVmed) has launched three new projects focused on the supply chain in West Africa.

Middle East and Africa Operations

Animalcare 2019 sales dip is precursor to COVID-19 impact and notable new products

UK firm Animalcare has reported a 2% dip in annual revenues as it continues to rebuild itself for a stronger future.

Financial Results Operations

Avivagen bolsters Mexico OxC-beta order after dairy study, snares more purchases

Avivagen has boosted orders of its OxC-beta Livestock from Mexico by securing positive results from two recent dairy field tests.

Feed & Additives Food Animals

Survey highlights uptake of telehealth, importance of continuous product supply

A survey has found the most negative impact of the COVID-19 pandemic on veterinary practices has been in clinic visits and over-the-counter (OTC) medications. 

Operations Companion Animals

Covetrus shares continue ascent out of COVID-19 lull

Covetrus' share value is now trading at its highest level since August 2019.

Markets Operations

Clinvet ups CRO offering in North America through TelemarkVet partnership

Clinvet is augmenting its contract research organization (CRO) offering in North America by collaborating with Telemark Veterinary Consulting.

Deals Operations

Zoetis shares complete recovery following COVID-19 downturn

Zoetis has seen its share price return to its highest level since the beginning of the COVID-19 pandemic.

Zoetis Markets

Kane recommences trading on early-stage US venture market

Canadian pet oral care firm Kane Biotech has resumed trading on the OCTCQB venture market.

Operations Markets
UsernamePublicRestriction

Register